We are live on ! Find out more
LCG

Lisanti Capital Growth Portfolio holdings

AUM $397M
1-Year Est. Return 178.66%
This Fund
S&P 500
This Quarter Est. Return
+16.65%
1 Year Est. Return
+178.66%
3 Year Est. Return
+1,089.72%
5 Year Est. Return
+3,176.57%
10 Year Est. Return
+120,936.2%
AUM
$308M
AUM Growth
+$25.4M
Cap. Flow
-$7.32M
Cap. Flow %
-2.38%
Top 10 Hldgs %
22.74%
Holding
140
New
27
Increased
41
Reduced
24
Closed
42

Top Buys

Rank Stock Value
1
WING icon
Wingstop
WING
+$7.21M
2
MTZ icon
MasTec
MTZ
+$5.53M
3
BLD
TopBuild
BLD
+$5.1M
4
AYX
Alteryx Inc
AYX
+$4.88M
5
NTRA icon
Natera
NTRA
+$4.57M

Sector Composition

Rank Sector Weight
1 Industrials 23.7%
2 Healthcare 23.02%
3 Technology 18.33%
4 Consumer Discretionary 17.79%
5 Consumer Staples 6.28%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
WGO icon
51
Winnebago Industries
WGO
$856M
$2.72M 0.88%
+70,270
New +$2.47M
CHGG icon
52
Chegg
CHGG
$110M
$2.61M 0.85%
67,565
+700
+1% +$26.4K
GKOS icon
53
Glaukos
GKOS
$9.83B
$2.4M 0.78%
31,770
+340
+1% +$24.4K
SWAV
54
DELISTED
Shockwave Medical, Inc. Common Stock
SWAV
$2.37M 0.77%
41,470
-16,640
-29% -$808K
EXAS
55
DELISTED
Exact Sciences
EXAS
$2.22M 0.72%
18,800
+6,015
+47% +$606K
GTLS
56
DELISTED
Chart Industries
GTLS
$2.22M 0.72%
28,865
-52,875
-65% -$4.34M
KBH icon
57
KB Home
KBH
$3.37B
$2.05M 0.67%
+79,640
New +$2.05M
FIVE icon
58
Five Below
FIVE
$12B
$2.03M 0.66%
16,915
+685
+4% +$90.2K
MASI
59
DELISTED
Masimo
MASI
$2M 0.65%
13,430
+5,790
+76% +$795K
GBT
60
DELISTED
Global Blood Therapeutics, Inc.
GBT
$1.98M 0.64%
37,670
+9,530
+34% +$548K
NSTG
61
DELISTED
NanoString Technologies, Inc.
NSTG
$1.81M 0.59%
59,620
-13,855
-19% -$367K
SMAR
62
DELISTED
Smartsheet Inc.
SMAR
$1.79M 0.58%
36,910
+26,105
+242% +$1.11M
EEFT icon
63
Euronet Worldwide
EEFT
$2.72B
$1.78M 0.58%
10,565
SGI
64
Somnigroup International
SGI
$13.7B
$1.77M 0.57%
+96,320
New +$1.55M
PODD icon
65
Insulet
PODD
$11.5B
$1.72M 0.56%
14,380
-3,065
-18% -$314K
TCMD icon
66
Tactile Systems Technology
TCMD
$635M
$1.71M 0.56%
30,045
+13,875
+86% +$723K
CSII
67
DELISTED
Cardiovascular Systems, Inc.
CSII
$1.59M 0.52%
+36,975
New +$1.44M
SLAB icon
68
Silicon Laboratories
SLAB
$7.17B
$1.58M 0.51%
+15,245
New +$1.47M
TRHC
69
DELISTED
Tabula Rasa HealthCare, Inc. Common Stock
TRHC
$1.56M 0.51%
31,155
+16,945
+119% +$843K
LYV icon
70
Live Nation Entertainment
LYV
$40.6B
$1.54M 0.5%
23,245
AGCO icon
71
AGCO
AGCO
$7.15B
$1.51M 0.49%
19,460
+1,075
+6% +$76.7K
LSCC icon
72
Lattice Semiconductor
LSCC
$17.6B
$1.49M 0.49%
102,325
-129,060
-56% -$1.72M
ZEN
73
DELISTED
ZENDESK INC
ZEN
$1.4M 0.45%
15,680
+4,490
+40% +$386K
BFAM icon
74
Bright Horizons
BFAM
$3.92B
$1.36M 0.44%
9,050
+4,110
+83% +$551K
HXL icon
75
Hexcel
HXL
$7.79B
$1.36M 0.44%
16,815

Similar funds

Lisanti Capital Growth's Q2 2019 Portfolio in Review

As of Q2 2019, Lisanti Capital Growth held 140 positions worth $308M, up 9% from $282M the previous quarter. Its ten largest holdings account for 23% of the portfolio.

Lisanti Capital Growth's Q2 2019 filing shows 27 new, 41 increased, 24 reduced and 42 closed positions. Its largest new stake was Wingstop: 88,540 shares worth $8.39M. The largest sale was Merit Medical Systems, an estimated $5.53M.

By sector, the portfolio is most concentrated in Industrials at 24% of assets, up from 17% a quarter earlier, followed by Healthcare and Technology.

  • Lisanti Capital Growth's largest Q2 2019 buy was Wingstop: 88,540 shares worth $8.39M.
  • Lisanti Capital Growth added most to Zscaler in Q2 2019, an estimated $3.64M increase.
  • Lisanti Capital Growth's biggest Q2 2019 reduction was Chart Industries, cutting an estimated $4.34M.
  • Lisanti Capital Growth fully exited Merit Medical Systems in Q2 2019, selling an estimated $5.53M.
  • Lisanti Capital Growth's ten largest holdings make up 23% of its $308M portfolio in Q2 2019.
  • Lisanti Capital Growth opened 27 new positions and closed 42 in Q2 2019.
  • Lisanti Capital Growth's portfolio value rose 9% quarter-over-quarter to $308M.

Based on Lisanti Capital Growth's 13F filing for Q2 2019, filed 5 Aug 2019.